WCBA
CMD

Weaver C. Barksdale & Associates’s Cantel Medical Corporation CMD Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-39,396
Closed -$2.81M – 551
2016
Q1 		$2.81M Buy
+39,396
New +$2.47M 2.11% 5

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Weaver C. Barksdale & Associates's CMD Position: Q2 2016 in Review

Weaver C. Barksdale & Associates sold out of Cantel Medical Corporation (CMD) in Q2 2016, closing a stake of 39,396 shares — an estimated $2.81M sold.

Weaver C. Barksdale & Associates first reported a position in CMD in Q1 2016 and held it in 1 quarter. The position peaked at $2.81M in Q1 2016. 231 funds tracked by Wall St. Rank hold CMD as of Q2 2016.

  • Weaver C. Barksdale & Associates reported no remaining Cantel Medical Corporation position as of Q2 2016 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 39,396 Cantel Medical Corporation shares in Q2 2016, an estimated $2.81M.
  • Weaver C. Barksdale & Associates first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 1 quarter.
  • Weaver C. Barksdale & Associates's Cantel Medical Corporation position peaked at $2.81M in Q1 2016.
  • 231 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2016.

Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2016, filed 11 Jul 2016.